Vincerx Pharma, Inc.'s (NASDAQ:VINC) large institutional owners must be happy as stock continues to impress, up 28% over the past week [Yahoo! Finance]
Vincerx Pharma, Inc. (VINC)
Company Research
Source: Yahoo! Finance
The top 9 shareholders own 50% of the company Insider ownership in Vincerx Pharma is 18% Every investor in Vincerx Pharma, Inc. ( NASDAQ:VINC ) should be aware of the most powerful shareholder groups. The group holding the most number of shares in the company, around 38% to be precise, is institutions. Put another way, the group faces the maximum upside potential (or downside risk). Last week's 28% gain means that institutional investors were on the positive end of the spectrum even as the company has shown strong longer-term trends. One-year return to shareholders is currently 347% and last week's gain was the icing on the cake. In the chart below, we zoom in on the different ownership groups of Vincerx Pharma. View our latest analysis for Vincerx Pharma What Does The Institutional Ownership Tell Us About Vincerx Pharma? Institutional investors commonly compare their own returns to the returns of a commonly followed index. So they generally do consider buying larger co
Show less
Read more
Impact Snapshot
Event Time:
VINC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VINC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VINC alerts
High impacting Vincerx Pharma, Inc. news events
Weekly update
A roundup of the hottest topics
VINC
News
- Vincerx Pharma Announces Pricing of Underwritten Public Offering of Common Stock and WarrantsGlobeNewswire
- Vincerx Pharma Announces Proposed Underwritten Public Offering of Common Stock and WarrantsGlobeNewswire
- Vincerx Pharma, Inc. (NASDAQ: VINC) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.MarketBeat
- Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 [Yahoo! Finance]Yahoo! Finance
- Vincerx Pharma Presents Positive Preliminary Phase 1 Data for VIP236 and Updates on Pipeline Progress at the American Association for Cancer Research (AACR) Annual Meeting 2024 GlobeNewswire
VINC
Sec Filings
- 4/26/24 - Form 8-K
- 4/25/24 - Form 8-K
- 4/25/24 - Form 424B5
- VINC's page on the SEC website